TSE:MFC

Manulife Financial (MFC.TO)

60.39
-0.28 (0.46%)
as of Jul 23, 2026, 6:04:18 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
HOLD
Results today were in line, and they posted an investment gain. Likes the positioning in Asia, a faster growing region. Valuation of PE and price to book value very attractive. Dividend safe at these levels. Next 2-3 years, good capital upside potential. Keep holding.
COMMENT
A very cheap stock. However, all financials have been hammered. Once covid struck, the markets melted. Central banks cut interest rates to almost 0. Interest rate sensitive stocks have been hammered. If we get a recovery, and there is inflation, interest rates will rise and stocks like MFC will rally significantly.
HOLD

More horsepower in Manulife than Power Corp for a similar business. MFC has better risk/reward long-term, with a good-sized dividend while you wait.

BUY
It is not an expensive stock. It has almost a 6% dividend. Low interest rates put pressure on these companies. Being a global wealth manager has helped offset the insurance business with low interests. This is a nice stock to buy.
BUY

He owns Sun Life and Great West Life instead. Insurers have suffered. Growthier companies are getting the attention, especially in a low interest rate environment. Good value over time, but that's not in favour right now. Has recovered from the March lows. Nothing against it.

BUY
Allan Tong’s Discover Picks The MFC trailing PE remains a low 9.6x while the forward PE is 6x. The price-to-book has stayed at 0.75x during this pandemic. The dividend yield is nearly 6% and is safe, based on a 54% payout ratio. Quarterly revenue growth YOY is 24.2%, though quarterly earnings have sunk nearly 50%. Read 3 Forgotten Undervalued Stocks: ZBRA Stock, MFC Stock and BBBY Stock for our full analysis.
TOP PICK
To allocate hard-earned money to live on, rather than chasing FANGs. Trading at 6.3x. Decent 10% growth rate. Not much downside. Nice dividend. A no-brainer at these levels. Yield is 5.74%. (Analysts’ price target is $23.37)
HOLD
The financial complex has been hit with low interest rates that has made it harder to make money on the lending spread. The liabilities are also valued at future claims so when interest rates go down, it is a headwind. The company is doing all the right things by reducing exposure to markets and their Asian operations are doing well.
BUY
The valuation is low with low price to book. The dividend is quite good. There is just negative sentiment around lifecos in general. The market has just not responded to what they are doing. Interest rates are likely to be low for a long time which is punitive to them.
PAST TOP PICK
(A Top Pick Jul 12/19, Down 10%) Good earnings, but hurt by the perception and reality of low interest rates. Trading less than 10x earnings. A bit contrarian, but still a good entry point around $20.
HOLD
Undervalued, solid yield, reasonable payout ratio. Caught up in the value trade. Scores in top 2% of valuation. Will do better when yields start to rise. Will catch a bid with inflation. Don't give up on it.
PAST TOP PICK
(A Top Pick Jul 11/19, Down 16%) All the financial companies, including insurance and the banks, have been hammered. Low interest rates makes it difficult for these companies to make profit. When confronted with issues like these, the company has done a fine job to develop new sources of earnings. Their earnings are as high or higher than last year, when he recommended the stock. The stock is tremendously cheap at this level.
TOP PICK
When prices get down to silly valuations you just have to buy. It is very, very cheap. It has been this cheap three times in the past 10 years, but the earnings just keep rising. Yield 5.86% (Analysts’ price target is $22.32)
BUY
An uneven ride. New CEO had done a good job focusing on higher growth areas and which legacy business to get rid of. All lifecos faced writedowns because of Covid. Trades at a low price to book value, and a discount to its peers. Favours its positioning in Asia, a higher growth area and a good growth opportunity. (Analysts’ price target is $22.00)
COMMENT
Based on fundamentals, why is this so low? Very low interest rates are a reason. Insurance companies are great when rates rise. MFC is well-managed and have turned around the company in the past company, and their Asian operations are a definite plus. MFC should return to $25-30 when rates and the wider economy recover.
Showing 286 to 300 of 2,283 entries